2'-fluoro-2'-deoxycytidine has been researched along with favipiravir in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Haverkamp, C; Liu, C; Schneller, SW | 1 |
| Bergeron, É; Chatterjee, P; Flint, M; Nichol, ST; Scholte, FEM; Spiropoulou, CF; Welch, SR | 1 |
| Li, Y; Miao, Z; Pan, Q; Peppelenbosch, MP; Wang, Y; Yu, P | 1 |
3 other study(ies) available for 2'-fluoro-2'-deoxycytidine and favipiravir
| Article | Year |
|---|---|
Enantiomeric 4'-truncated 6'-fluoro-3-deazaneplanocin and its 3-bromo derivative: Synthesis and antiviral properties, including Ebola and Marburg.
Topics: Adenosine; Antiviral Agents; Dose-Response Relationship, Drug; Ebolavirus; Marburgvirus; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2021 |
Identification of 2'-deoxy-2'-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus.
Topics: Amides; Antiviral Agents; Cell Line, Tumor; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Discovery; Drug Synergism; Genes, Reporter; Green Fluorescent Proteins; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, Crimean; High-Throughput Screening Assays; Humans; Lethal Dose 50; Pyrazines; Ribavirin; Viral Proteins; Virus Replication | 2017 |
2'-Fluoro-2'-deoxycytidine inhibits murine norovirus replication and synergizes MPA, ribavirin and T705.
Topics: Amides; Animals; Antiviral Agents; Caliciviridae Infections; Cell Line; Deoxycytidine; Humans; Mice; Mycophenolic Acid; Norovirus; Pyrazines; RAW 264.7 Cells; Ribavirin; Virus Replication | 2020 |